Paper39891710
Interaction between Estrogen Receptors and p53: A Broader Role for Tamoxifen?
Das GM and 2 others. Endocrinology, 2025. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Interaction between Estrogen Receptors and p53: A Broader Role for Tamoxifen? Papers, record 39891710. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39891710
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Tamoxifen | Major topic |
| Breast Neoplasms | Major topic |
| Tumor Suppressor Protein p53 | Major topic |
| Antineoplastic Agents, Hormonal | Major topic |
| Estrogen Receptor alpha | Major topic |
| Receptors, Estrogen | Major topic |
| Humans | |
| Female | |
| Animals | |
| Selective Estrogen Receptor Modulators |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA016056 | NCI NIH HHS | United States | P30CA016056 | PubMed and NIH | NIH RePORTER |
| BC180932 | DOD BCRP Breakthrough Award | PubMed | PubMed | ||
| P30CA016056 | NCI NIH HHS | United States | P30CA016056 | PubMed and NIH | NIH RePORTER |
| R01 CA251545 | NCI NIH HHS | United States | R01CA251545 | PubMed and NIH | NIH RePORTER |
| R21CA137635 | NIH HHS | United States | R21CA137635 | PubMed and NIH | NIH RePORTER |
| Breast Cancer Coalition of Rochester | PubMed | PubMed | |||
| The Jayne & Phil Hubbell Family and Roswell Park Alliance Foundation Grant | PubMed | PubMed |
References156
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36772966 | Therapeutic Role of Tamoxifen for Triple-Negative Breast Cancer: Leveraging the Interaction Between ERβ and Mutant p53. | Oncologist | 2023 | https://conductscience.org/library/papers/36772966 | PubMed |
| 2 | 26164151 | RAD1901: a novel, orally bioavailable selective estrogen receptor degrader that demonstrates antitumor activity in breast cancer xenograft models. | Anticancer Drugs | 2015 | https://conductscience.org/library/papers/26164151 | PubMed |
| 3 | 5140877 | Estrogen receptors and breast cancer response to adrenalectomy. | Natl Cancer Inst Monogr | 1971 | https://conductscience.org/library/papers/5140877 | PubMed |
| 4 | 10802655 | A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. | Nat Genet | 2000 | https://conductscience.org/library/papers/10802655 | PubMed |
| 5 | 38643482 | Estrogen Receptor Alpha Mutations, Truncations, Heterodimers, and Therapies. | Endocrinology | 2024 | https://conductscience.org/library/papers/38643482 | PubMed |
| 6 | 11606748 | p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis. | Proc Natl Acad Sci U S A | 2001 | https://conductscience.org/library/papers/11606748 | PubMed |
| 7 | 10652267 | The coregulator exchange in transcriptional functions of nuclear receptors. | Genes Dev | 2000 | https://conductscience.org/library/papers/10652267 | PubMed |
| 8 | 11162944 | From ligand to response: generating diversity in nuclear receptor coregulator function. | J Steroid Biochem Mol Biol | 2000 | https://conductscience.org/library/papers/11162944 | PubMed |
| 9 | 37208678 | Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival. | BMC Cancer | 2023 | https://conductscience.org/library/papers/37208678 | PubMed |
| 10 | 23954741 | Estrogen receptor beta in breast cancer. | Mol Cell Endocrinol | 2014 | https://conductscience.org/library/papers/23954741 | PubMed |
| 11 | 9828250 | Tamoxifen in the treatment of breast cancer. | N Engl J Med | 1998 | https://conductscience.org/library/papers/9828250 | PubMed |
| 12 | 16141321 | An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. | Proc Natl Acad Sci U S A | 2005 | https://conductscience.org/library/papers/16141321 | PubMed |
| 13 | 39232441 | Elacestrant in ESR1-mutant, endocrine-responsive metastatic breast cancer: should health authorities consider post hoc data to inform priority access? | ESMO Open | 2024 | https://conductscience.org/library/papers/39232441 | PubMed |
| 14 | 16495339 | Functional estrogen receptors in the mitochondria of breast cancer cells. | Mol Biol Cell | 2006 | https://conductscience.org/library/papers/16495339 | PubMed |
| 15 | 35304506 | Clinical associations of ESR2 (estrogen receptor beta) expression across thousands of primary breast tumors. | Sci Rep | 2022 | https://conductscience.org/library/papers/35304506 | PubMed |
| 16 | 26871946 | ERβ decreases the invasiveness of triple-negative breast cancer cells by regulating mutant p53 oncogenic function. | Oncotarget | 2016 | https://conductscience.org/library/papers/26871946 | PubMed |
| 17 | 30863105 | Brain metastases from breast cancer may respond to endocrine therapy: report of two cases. | Onco Targets Ther | 2019 | https://conductscience.org/library/papers/30863105 | PubMed |
| 18 | 27806348 | Clinical outcomes based on multigene profiling in metastatic breast cancer patients. | Oncotarget | 2016 | https://conductscience.org/library/papers/27806348 | PubMed |
| 19 | 17699779 | Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis. | Cancer Res | 2007 | https://conductscience.org/library/papers/17699779 | PubMed |
| 20 | 33705209 | Next-Generation Endocrine Therapies for Breast Cancer. | J Clin Oncol | 2021 | https://conductscience.org/library/papers/33705209 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42680785 | Targeting hormone treatment for the brain in menopause. | Sci Rep | 2026 | https://conductscience.org/library/papers/42680785 | PubMed |
| 41945945 | The Combined Effects of Eleutherine bulbosa Ethanol Extract and Tamoxifen On Cox-2 Levels in a BaLB/c Mouse Breast Cancer Model. | Asian Pac J Cancer Prev | 2026 | https://conductscience.org/library/papers/41945945 | PubMed |
| 41878526 | Real-world precision medicine data in metastatic prostate cancer - a retrospective cohort study. | Front Oncol | 2026 | https://conductscience.org/library/papers/41878526 | PubMed |
| 41712374 | Effectiveness of Non-Pharmacological Interventions for Hormone Therapy-Induced Hand Arthralgia in Breast Cancer Patients: A Systematic Review. | J Evid Based Integr Med | 2026 | https://conductscience.org/library/papers/41712374 | PubMed |
| 41193244 | Mutant p53 binds and controls estrogen receptor activity to drive endocrine resistance in ovarian cancer. | Genes Dev | 2026 | https://conductscience.org/library/papers/41193244 | PubMed |
| 41131199 | MED1 IDR deacetylation controls stress responsive genes through RNA Pol II recruitment. | Nat Chem Biol | 2026 | https://conductscience.org/library/papers/41131199 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| ESR1 | 2099 | PubTator's text mining | https://conductscience.org/library/genes/2099 | NCBI Gene |
| ESR2 | 2100 | PubTator's text mining | https://conductscience.org/library/genes/2100 | NCBI Gene |
| PGR | 5241 | PubTator's text mining | https://conductscience.org/library/genes/5241 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39891710
GET https://conductscience.org/api/papers/v1/39891710/references?page=2